0001140361-14-037288.txt : 20141003 0001140361-14-037288.hdr.sgml : 20141003 20141003143521 ACCESSION NUMBER: 0001140361-14-037288 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141002 FILED AS OF DATE: 20141003 DATE AS OF CHANGE: 20141003 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lewicki John A. CENTRAL INDEX KEY: 0001553352 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 141139383 MAIL ADDRESS: STREET 1: C/O ONCOMED PHARMACEUTICALS, INC. STREET 2: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc1.xml FORM 4 X0306 4 2014-10-02 0 0001302573 OncoMed Pharmaceuticals Inc OMED 0001553352 Lewicki John A. C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 0 1 0 0 EVP & Chief Scientific Officer Common Stock 2014-10-02 4 M 0 5809 1.43 A 26411 D Common Stock 2014-10-02 4 S 0 5809 20.00 D 20602 D Common Stock 82928 I See Footnote Stock Option (Right to Buy) 1.43 2014-10-02 4 M 0 5809 0 D 2017-01-11 Common Stock 5809 56277 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 13, 2014. Includes 20,000 restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit. The shares are held by John Allan Lewicki and Jenniffer Joan Lewicki, Trustees of the Lewicki Family Trust dated December 6, 2000. The option is fully vested and exercisable, subject to an annual limitation of 175,438 shares that can be issued to a single grantee upon the exercise of awards under the Issuer's 2004 Stock Incentive Plan. /s/ Alicia J. Hager, Attorney-in-Fact for John A. Lewicki 2014-10-03